Research Article

Preparation, Optimization, and Screening of the Effect of Processing Variables on Agar Nanospheres Loaded with Bupropion HCl by a D-Optimal Design

Table 1

Design of the experiment according to a D-optimal design for formulating agar nanospheres loaded with bupropion HCl.

FormulationCaCl2 (%)Homogenizer speed (rpm)Agar (%)HPCD (%)Particle size (nm)Zeta potential (mV)Loading efficiency (%)RE300 (%)PdI

C10S8000A2H110800021534.5 ± 18.6−31.534.7 ± 0.390 ± 30.22
C6S10000A2H0.561000020.5716.2 ± 163.7−32.831.4 ± 1.163 ± 60.62
C10S8000A2H110800021525.9 ± 63.7−30.241.5 ± 1.279 ± 40.54
C10S12000A1H0101200010613.4 ± 146.1−27.229.4 ± 1.881 ± 100.56
C2S8000A2H02800020406.5 ± 79.6−31.744.6 ± 2.770 ± 70.53
C6S10000A1.5H06100001.50503.9 ± 181.3−31.035.4 ± 2.286 ± 80.45
C2S10000A2H121000021504.5 ± 114.8−28.038.9 ± 0.980 ± 80.99
C6S8000A1.5H0.5680001.50.5807.2 ± 86−25.939.5 ± 1.584 ± 50.51
C2S12000A1H121200011491.3 ± 29.9−22.918.9 ± 2.084 ± 260.38
C10S10000A1.5H0.510100001.50.5492.3 ± 54.9−25.434.9 ± 2.384 ± 170.9
C10S12000A1H0101200010310.3 ± 10.4−21.727.7 ± 1.077 ± 70.33
C2S8000A1H12800011659.1 ± 80.2−29.920.8 ± 0.786 ± 90.21
C6S8000A1H06800010670.1 ± 159.5−27.918.9 ± 0.472 ± 80.73
C2S12000A2H021200020519.7 ± 74.3−34.243.6 ± 0.378 ± 40.48
C2S8000A2H02800020713.4 ± 97.3−35.240.0 ± 1.078 ± 30.42
C10S12000A2H1101200021494.5 ± 19.3−29.836.3 ± 0.391 ± 60.52
C10S8000A1H0.510800010.5723.2 ± 304.7−24.632.1 ± 0.587 ± 20.61
C6S10000A1.5H16100001.51455.3 ± 153.3−31.337.2 ± 0.686 ± 30.69
C10S10000A2H0101000020453.2 ± 19−30.044.3 ± 0.978 ± 20.25
C10S8000A1.5H01080001.50619.9 ± 132.2−28.045.6 ± 2.287 ± 100.63
C4S11000A1.25H0.54110001.250.5443.4 ± 22.9−34.731.7 ± 0.785 ± 40.72
C10S12000A2H1101200021674.1 ± 79.1−31.730.0 ± 1.187 ± 50.47
C10S10000A1H1101000011357.3 ± 7.9−29.026.6 ± 1.365 ± 40.58
C2S12000A2H021200020641.7 ± 32.0−27.344.1 ± 2.467 ± 50.51
C2S10000A1H021000010776.6 ± 50.1−37.136.6 ± 1.174 ± 40.54

C: CaCl2, S: speed of homogenizer, A: agar, and H: hydroxyl -cyclodextrin.